Cargando…

Is there a difference in rhythm outcome between patients undergoing first line versus second line paroxysmal atrial fibrillation ablation?

BACKGROUND: Catheter ablation of atrial fibrillation (AF) is an established second line therapy for patients with symptomatic paroxysmal AF (PAF) and may be considered as a first line therapy in selected patients who are highly symptomatic, considering patient choice, benefit, and risk, according to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manninger, Martin, Ebner, Jakob, Zweiker, David, Sieghartsleitner, Raphael, Mastnak, Bernadette, Bisping, Egbert, Lercher, Peter, Riedlbauer, Rita, Rotman, Brigitte, Brussee, Helmut, Scherr, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6285381/ https://www.ncbi.nlm.nih.gov/pubmed/30532216 http://dx.doi.org/10.1371/journal.pone.0208994

Ejemplares similares

Electroanatomic mapping system guided His bundle pacemaker implantation: experience of the His bundle registry graz
por: Benedikt, M, et al.
Publicado: (2023)

Incidence, types and predictors of AF recurrence after AF ablation with pulsed field ablation. A single-centre experience
por: Eberl, A, et al.
Publicado: (2023)

Post-cardiac injury syndrome triggered by radiofrequency ablation for AVNRT
por: Wenzl, Florian A., et al.
Publicado: (2021)

Oversensing of the wearable cardioverter defibrillator during bipolar ventricular stimulation
por: Manninger, Martin, et al.
Publicado: (2017)

First-Line Approach for Rhythm Control in Paroxysmal Atrial Fibrillation: Which Is the Optimal Treatment?
por: Bisignani, Antonio, et al.
Publicado: (2022)

Impact of Catheter Ablation for Atrial Fibrillation on Quality of Life
por: Rohrer, Ursula, et al.
Publicado: (2022)

Sniff of coke breaks the heart: cocaine-induced coronary vasospasm aggravated by therapeutic hypothermia and vasopressors after aborted sudden cardiac death: a case report
por: Manninger, Martin, et al.
Publicado: (2018)

Cryoballoon ablation vs. antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation
por: Kuniss, Malte, et al.
Publicado: (2021)

Role of wearable rhythm recordings in clinical decision making—The wEHRAbles project
por: Manninger, Martin, et al.
Publicado: (2020)

RAAFT-2: Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation
por: Kaba, Riyaz A, et al.
Publicado: (2014)

Medical Therapy, Radiofrequency Ablation, or Cryoballoon Ablation as First-Line Treatment for Paroxysmal Atrial Fibrillation: Interpreting Efficacy Through the Shiny Method
por: Trippoli, Sabrina, et al.
Publicado: (2022)

Wearable cardioverter-defibrillator as bridging to ICD in pediatric hypertrophic cardiomyopathy with myocardial bridging – a case report
por: Kurath-Koller, Stefan, et al.
Publicado: (2020)

In The Line of Treatment: A Systematic Review of Paroxysmal Supraventricular Tachycardia
por: Ahmad, Farrukh, et al.
Publicado: (2021)

Prevention of Early Sudden Cardiac Death after Myocardial Infarction Using the Wearable Cardioverter Defibrillator—Results from a Real-World Cohort
por: Rohrer, Ursula, et al.
Publicado: (2023)

Expert consensus on acute management of ventricular arrhythmias – VT network Austria()
por: Martinek, M., et al.
Publicado: (2021)

An economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from an English NHS perspective
por: Andrade, J, et al.
Publicado: (2023)

Cryoballoon Ablation for Patients With Paroxysmal Atrial Fibrillation
por: Suenari, Kazuyoshi, et al.
Publicado: (2020)

Acute hyperglycaemia is not associated with the development of atrial fibrillation in healthy pigs
por: Manninger, Martin, et al.
Publicado: (2020)

Electrophysiological findings during re-do procedures after single-shot pulmonary vein isolation for atrial fibrillation with pulsed field ablation
por: Magni, F T, et al.
Publicado: (2023)

Brady- and tachyarrhythmias detected by continuous rhythm monitoring in paroxysmal atrial fibrillation
por: Frausing, Maria Hee Jung Park, et al.
Publicado: (2023)

An economic evaluation of first-line cryoballoon ablation vs antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from a U.S. Medicare perspective
por: Wazni, Oussama, et al.
Publicado: (2023)

Paroxysmal Atrial Fibrillation Ablation Using a Novel Variable-Loop Biphasic Pulsed Field Ablation Catheter Integrated With a 3-Dimensional Mapping System: 1-Year Outcomes of the Multicenter inspIRE Study
por: Duytschaever, Mattias, et al.
Publicado: (2023)

An Unusual Presentation of Paroxysmal Atrial Fibrillation Following Ablation
por: Kerosky, Zachary P, et al.
Publicado: (2022)

Electrophysiological findings during re-do procedures after single-shot pulmonary vein isolation for atrial fibrillation with pulsed field ablation
por: Magni, Federico Tancredi, et al.
Publicado: (2023)

Correction: Electrophysiological findings during re-do procedures after single-shot pulmonary vein isolation for atrial fibrillation with pulsed field ablation
por: Magni, Federico Tancredi, et al.
Publicado: (2023)

Atrial contractile function and fibrosis in patients with paroxysmal atrial fibrillation in sinus rhythm
por: Yaroslav, Ashikhmin, et al.
Publicado: (2022)

Size matters - body size and acute device-implantation failure after LAAC
por: Zweiker, D, et al.
Publicado: (2023)

Single-center outcome after ablation of atrial fibrillation using very high-power short duration pulmonary vein isolation
por: Rohrer, U, et al.
Publicado: (2023)

Ablation as First-line Therapy for Atrial Fibrillation
por: Andrade, Jason G
Publicado: (2023)

Photoplethysmography-documented atrial fibrillation in the first week after catheter ablation is associated with lower success rates
por: Manninger, Martin, et al.
Publicado: (2023)

Catheter Ablation vs. Anti-Arrhythmic Drugs as First-Line Treatment in Symptomatic Paroxysmal Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Saglietto, Andrea, et al.
Publicado: (2021)

Gastro-Esophageal Reflux Disease and Paroxysmal Atrial Fibrillation Ablation
por: Floria, Mariana, et al.
Publicado: (2023)

Deep-Learning-Based Detection of Paroxysmal Supraventricular Tachycardia Using Sinus-Rhythm Electrocardiograms
por: Wang, Lei, et al.
Publicado: (2022)

Multiparameter Monitoring with a Wearable Cardioverter Defibrillator
por: Rohrer, Ursula, et al.
Publicado: (2021)

The effect of left atrial remodeling after cryoballoon ablation and radiofrequency ablation for paroxysmal atrial fibrillation
por: Wang, Xule, et al.
Publicado: (2020)

Ostial vs. wide area circumferential ablation guided by the Ablation Index in paroxysmal atrial fibrillation
por: Sousa, Pedro A, et al.
Publicado: (2023)

Short‐term and long‐term effects of cryoballoon ablation versus antiarrhythmic drug therapy as first‐line treatment for paroxysmal atrial fibrillation: A systematic review and meta‐analysis
por: Liu, Zirui, et al.
Publicado: (2023)

Efficacy of ablation at the anteroseptal line for the treatment of perimitral flutter
por: Abi-Saleh, Bernard, et al.
Publicado: (2015)

Very High-Power Short-Duration (HPSD) Ablation for Pulmonary Vein Isolation: Short and Long-Term Outcome Data
por: Seidl, Sebastian, et al.
Publicado: (2022)

Cryoballoon Ablation for Paroxysmal Atrial Fibrillation in Septuagenarians: a Prospective Study
por: Chierchia, Gian Battista, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_0h4a3o9pevmqeq4n5d5r238h4h